This is the moment right here. My level I’ve been waiting for. Time
To long ?! This will be the third touch at same area we tapped and ran both times last time. Will history repeats ? I will take this chance stops below or cut upon closing candle below support. Good luck
Patience here as we could retest lower support for the 3rd tap. Last 2 tests caused a sick rally. Will the 3rd tap do the same? Or will this support break as we now put in a lower high? I’d be watching 17$ if we hold and bounce, targeting half off at the downtrendinf resistance of the last 2 highs. This next push may reject aroubd 21$ But blasting through could...
Probably wont be in this until monday as want to see how markets will open.
XBI looking like a leading sector
EXCEL multiple daily closes above EMA cloud + Retest and push higher of 200EMA
HOWEVER - Missing volume on todays move higher.
2 TP marked on chart
Tight stop as always
Entry: $23.00
SL: $21.80 (loss 5.4 %) (visual only, close if daily closing price below)
TP: $29 (profit 27 %, ratio 5)
Hello Trader,
Exelixis is building a bullish flag right now. After the upper trend line is broken, a buy signal is created. I like the risk-reward ratio.
Deutsch
Hallo Trader,
Exelixis buildet gerade eine bullische Flagge aus. Nachdem die...
consolidation on previous resiatnce this is gearing up for a huge pop. might need more time to consildate but man its getting ready! all eyes on this pharma
I'm cautious with this trade. I don't usually get into positions with a risk/reward smaller than 3.
- Target Entry: $25.65
- Target Stop Loss: $25.05
- Target Exit: $27.19
- Risk / Reward Ratio: 2.57
About me
- Note that I tend to adjust stop losses in order to secure profits early and preserve capital. This means that the target price is going to be achieved...
Hi guys, hope you are all well. Today we are looking at Exelixis, an oncology-focused biotechnology company that focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The market cap of the firm is roughly $7 billion. What drew me to looking into this company was its cash and cash equivalents value, a...
1st published idea for my new process which begins with the stock screener. I am trying to identify stocks that have bottomed out or at least hit a lower resistance that begin to have upwards momentum in the RSI coupled with an EMA crossover event.
Initial Filters:
>2B Market Cap to filter small companies
Debt to Equity Ratio (MRQ) < 0.5 to mitigate some...
Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company’s products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ capsules for the...
The company pre announced improved earnings and guidance over the weekend.
stock was in a channel ( bull-flag)
potential entry above POC @ $25
target $27.25
I feel like this could turn into another false down-break, but it is getting close to a breakout.
There is a good amount of volume that has been leveling out nicely, and I would expect a breakout later in the week, but this might another opportunity. However, buyers have had a little more control over this, and it's already broken through 1 of the major supports.
